Novel Software Systems
Private Company
Funding information not available
Overview
NOVEL is a privately held, revenue-generating bioinformatics software and services company founded in 2004, with a strong operational footprint in Russia, the US, China, and the Netherlands. Its core business revolves around two main platforms: 'NGS Wizard' for automated NGS data processing and 'Protomenal' for functional protein analysis, both designed to be accessible to users without deep technical expertise. With a team of over 50 specialists, the company leverages its interdisciplinary expertise to solve complex problems at the intersection of biology, mathematics, and IT, positioning itself in the high-growth markets of AI, personalized medicine, and genomic services.
Technology Platform
Proprietary bioinformatics software platforms for automated NGS data processing (NGS Wizard) and functional protein analysis (Protomenal), integrated with big data processing, cloud computing, and machine learning/AI capabilities.
Opportunities
Risk Factors
Competitive Landscape
NOVEL competes in the crowded bioinformatics software and services market against large players like Illumina (BaseSpace), QIAGEN (CLC Bio), Thermo Fisher, and pure-play software companies like DNAnexus and Partek, as well as numerous academic and open-source tools. Its differentiation lies in emphasizing ease-of-use for non-experts and a combined focus on genomics and proteomics.